APA
MRNA icon

American Portfolios Advisors’s Moderna MRNA Stock Holding History

American Portfolios Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.39M Buy
11,783
+4,823
+69% +$732K 0.06% 326
2022
Q2 		$994K Sell
6,960
-109
-2% -$15.6K 0.04% 437
2022
Q1 		$1.22M Buy
7,069
+713
+11% +$120K 0.04% 425
2021
Q4 		$1.61M Sell
6,356
-1,228
-16% -$359K 0.05% 334
2021
Q3 		$2.92M Buy
7,584
+2,308
+44% +$851K 0.11% 190
2021
Q2 		$1.24M Buy
5,276
+162
+3% +$29K 0.05% 378
2021
Q1 		$670K Buy
5,114
+101
+2% +$14.6K 0.03% 550
2020
Q4 		$524K Buy
5,013
+2,714
+118% +$275K 0.03% 546
2020
Q3 		$163K Buy
2,299
+290
+14% +$20.2K 0.01% 881
2020
Q2 		$129K Buy
2,009
+1,609
+402% +$88.1K 0.01% 910
2020
Q1 		$12K Buy
+400
New +$9.2K ﹤0.01% 1738

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

American Portfolios Advisors's MRNA Position: Q3 2022 in Review

American Portfolios Advisors increased its Moderna (MRNA) stake by 69% in Q3 2022, buying an estimated $732K and bringing the position to 11,783 shares worth $1.39M. The position accounts for 0.06% of the portfolio, ranked #326.

American Portfolios Advisors first reported a position in MRNA in Q1 2020 and has held it in 11 quarters since. The position peaked at $2.92M in Q3 2021. 916 funds tracked by Wall St. Rank hold MRNA as of Q3 2022.

  • American Portfolios Advisors held 11,783 shares of Moderna worth $1.39M as of Q3 2022.
  • American Portfolios Advisors bought 4,823 Moderna shares in Q3 2022, an estimated $732K.
  • Moderna made up 0.06% of American Portfolios Advisors's portfolio in Q3 2022, its #326 holding.
  • American Portfolios Advisors first reported a position in Moderna in Q1 2020 and has held it in 11 quarters since.
  • American Portfolios Advisors's Moderna position peaked at $2.92M in Q3 2021.
  • 916 funds tracked by Wall St. Rank held Moderna as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.